Marion McCourt; Executive Vice President - Commercial; Regeneron Pharmaceuticals Inc. Christopher Fenimore; Chief Financial Officer, Senior Vice President - Finance; Regeneron Pha ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $12.07, up 2% year-over-year, beating the ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

Regeneron (NASDAQ: REGN )'s flagship eye drug franchise, consisting of EYLEA HD and EYLEA, saw U.S. net sales increase 2% to ...

Biotech company Regeneron (NASDAQ:REGN) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up ...

Reports Q4 revenue $3.79B, consensus $3.75B. “Regeneron’s (REGN) financial and commercial strength allows for continued investment in our ...

KB Home Chairman and CEO Jeffrey Mezger said the company, based in the Westwood neighborhood of Los Angeles, is fully operational, though some of its employees have been affected by the fires.

Los Angeles Clippers star forward Kawhi Leonard has stepped away from the team in order to help members of his family who were forced to evacuate due to the Southern California wildfires ...

“Leonard Peltier’s freedom today is the result of 50 years of intergenerational resistance, organizing, and advocacy,” said Nick Tilsen, NDN Collective Founder and CEO. “Leonard Peltier ...

Ahead of that presentation, Leonard Schleifer, board co-chair, president and CEO of Regeneron, stated: “The Regeneron name is synonymous with innovation, brought to life through proprietary ...